OLVIG
TMDX icon

Oliver Lagore Vanvalin Investment Group’s Transmedics TMDX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-164
Closed -$12.9K – 821
2023
Q4 		$12.9K Sell
164
-79
-33% -$4.77K ﹤0.01% 375
2023
Q3 		$13.3K Sell
243
-21
-8% -$1.51K 0.01% 394
2023
Q2 		$22.2K Buy
264
+159
+151% +$12.2K 0.01% 354
2023
Q1 		$7.95K Buy
105
+21
+25% +$1.45K ﹤0.01% 418
2022
Q4 		$5.18K Buy
84
+7
+9% +$372 ﹤0.01% 463
2022
Q3 		$3K Buy
+77
New +$3.35K ﹤0.01% 507

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's TMDX Position: Q1 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Transmedics (TMDX) in Q1 2024, closing a stake of 164 shares — an estimated $12.9K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in TMDX in Q3 2022 and held it in 6 quarters. The position peaked at $22.2K in Q2 2023. 263 funds tracked by Wall St. Rank hold TMDX as of Q1 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Transmedics position as of Q1 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 164 Transmedics shares in Q1 2024, an estimated $12.9K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Transmedics in Q3 2022 and held it in 6 quarters.
  • Oliver Lagore Vanvalin Investment Group's Transmedics position peaked at $22.2K in Q2 2023.
  • 263 funds tracked by Wall St. Rank held Transmedics as of Q1 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q1 2024, filed 15 May 2024.